clonazepam has been researched along with Neonatal Abstinence Syndrome in 3 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case is described of a neonate who suffered from withdrawal symptoms within 24 hours after birth as a result of the use of clomipramine by the mother during pregnancy." | 7.68 | [Neonatal withdrawal symptoms following the use of clomipramine during pregnancy]. ( Boringa, JB; de Jong, GM; Touw, DJ, 1992) |
| "The case is described of a neonate who suffered from withdrawal symptoms within 24 hours after birth as a result of the use of clomipramine by the mother during pregnancy." | 3.68 | [Neonatal withdrawal symptoms following the use of clomipramine during pregnancy]. ( Boringa, JB; de Jong, GM; Touw, DJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oberlander, TF | 1 |
| Misri, S | 1 |
| Fitzgerald, CE | 1 |
| Kostaras, X | 1 |
| Rurak, D | 1 |
| Riggs, W | 1 |
| Murray, KL | 1 |
| Miller, KM | 1 |
| Pearson, DL | 1 |
| Boringa, JB | 1 |
| de Jong, GM | 1 |
| Touw, DJ | 1 |
3 other studies available for clonazepam and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Cohort Studies; Depressive Disorder; Dose | 2004 |
Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.
Topics: Antidepressive Agents, Second-Generation; Benzodiazepines; Clonazepam; Humans; Infant, Newborn; Male | 2007 |
[Neonatal withdrawal symptoms following the use of clomipramine during pregnancy].
Topics: Adult; Clomipramine; Clonazepam; Depressive Disorder; Female; Humans; Infant, Newborn; Male; Neonata | 1992 |